Science Corporation's brain tech is worth $3.5 billion after new funding

Science Corp raised a $400 million Series D to scale up its anti-blindness business.

Science Corporation's brain tech is worth $3.5 billion after new funding

TL;DR

  • Science Corporation raised $400 million in a Series D funding round, valuing the company at $3.5 billion.
  • The startup was founded in 2021 by former Neuralink president Max Hodak.
  • Their first product, PRIMA, is a wearable and implantable chip designed to restore vision for those with age-related macular degeneration.
  • PRIMA is approved in Europe and is currently being trialled for Stargardt's disease.
  • The company aims to bring PRIMA to the U.S. via the FDA's Humanitarian Device Exemption.
  • Science Corporation's long-term goal is to connect directly to the human brain with a bio-hybrid sensor.
  • Initial human trials for brain-related conditions are being designed with Yale neurosurgery professor Murat Günel.